These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15836585)

  • 1. Outpatient continuous intravenous dihydroergotamine for refractory headache.
    Charles JA
    Headache; 2005 Apr; 45(4):394-5. PubMed ID: 15836585
    [No Abstract]   [Full Text] [Related]  

  • 2. Outpatient home-based continuous intravenous dihydroergotamine therapy for intractable migraine.
    Charles JA; von Dohln P
    Headache; 2010 May; 50(5):852-60. PubMed ID: 20132337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous dihydroergotamine for inpatient management of refractory primary headaches.
    Nagy AJ; Gandhi S; Bhola R; Goadsby PJ
    Neurology; 2011 Nov; 77(20):1827-32. PubMed ID: 22049203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous intravenous dihydroergotamine in the treatment of intractable headache.
    Ford RG; Ford KT
    Headache; 1997 Mar; 37(3):129-36. PubMed ID: 9100396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient intravenous dihydroergotamine for refractory cluster headache.
    Magnoux E; Zlotnik G
    Headache; 2004 Mar; 44(3):249-55. PubMed ID: 15012663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Outpatient Dihydroergotamine Infusion With Interdisciplinary Care to Treat Refractory Pediatric Migraine: Preliminary Outcomes From the Comprehensive Aggressive Migraine Protocol ("CAMP").
    Connelly M; Sekhon S; Stephens D; Boorigie M; Bickel J
    Headache; 2020 Jan; 60(1):101-109. PubMed ID: 31626335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroergotamine and metoclopramide in the treatment of organic headache.
    Gross DW; Donat JR; Boyle CA
    Headache; 1995; 35(10):637-8. PubMed ID: 8550366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of headache related to intravenous immunoglobulin with antimigraine medications.
    Finkel AG; Howard JF; Mann JD
    Headache; 1998 Apr; 38(4):317-21. PubMed ID: 9595875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and Cost of Inpatient Hospitalization for Intravenous Dihydroergotamine Treatment of Refractory Pediatric Headache.
    Nelson GR; Bale JF; Kerr LM
    Pediatr Neurol; 2017 Jan; 66():76-81. PubMed ID: 27847180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ambulatory care of chronic headache secondary to abuse of ergot preparations].
    Cano A; Roquer J
    Aten Primaria; 1996 Feb; 17(3):179-81. PubMed ID: 8664427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of subcutaneous dihydroergotamine by home injection for migraine.
    Becker WJ; Riess CM; Hoag J
    Headache; 1996 Mar; 36(3):144-8. PubMed ID: 8984085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial.
    Silberstein SD; Young WB; Hopkins MM; Gebeline-Myers C; Bradley KC
    Headache; 2007 Jun; 47(6):878-85. PubMed ID: 17578539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical inquiries. What is the best treatment for analgesic rebound headaches?
    McPherson V; Leach L; Erlanger L
    J Fam Pract; 2005 Mar; 54(3):277-8. PubMed ID: 15755384
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache.
    Swidan SZ; Lake AE; Saper JR
    Curr Pain Headache Rep; 2005 Feb; 9(1):65-70. PubMed ID: 15625028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine: exploring its potential role and dosing guideline for its use in intractable pain in the palliative care setting.
    Coyne PJ; Wozencraft CP; Roberts SB; Bobb B; Smith TJ
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):384-6. PubMed ID: 21133747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of ketamine infusion in the treatment of intractable cancer pain in an outpatient.
    Chung WJ; Pharo GH
    J Pain Symptom Manage; 2007 Jan; 33(1):2-5. PubMed ID: 17196899
    [No Abstract]   [Full Text] [Related]  

  • 17. DHE in the pharmacotherapy of migraine: potential for a larger role.
    Saper JR; Silberstein S; Dodick D; Rapoport A
    Headache; 2006 Nov; 46 Suppl 4():S212-20. PubMed ID: 17078853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache.
    Lu SR; Fuh JL; Juang KD; Wang SJ
    Headache; 2000 Oct; 40(9):724-9. PubMed ID: 11091290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abortive headache therapy with intramuscular dihydroergotamine.
    Saadah HA
    Headache; 1992 Jan; 32(1):18-20. PubMed ID: 1555927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of acute intractable headaches using i.v. therapy in an office setting.
    Stiller J
    Headache; 1992 Nov; 32(10):514-5. PubMed ID: 1468912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.